EUR 230.5
(0.26%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 9.75 Billion EUR | 39.81% |
2022 | 6.97 Billion EUR | 22.46% |
2021 | 5.69 Billion EUR | 21.3% |
2020 | 4.69 Billion EUR | 65.15% |
2019 | 2.84 Billion EUR | 12.56% |
2018 | 2.52 Billion EUR | 9.97% |
2017 | 2.29 Billion EUR | 31.07% |
2016 | 1.75 Billion EUR | 21.97% |
2015 | 1.43 Billion EUR | 12.95% |
2014 | 1.27 Billion EUR | 8.35% |
2013 | 1.17 Billion EUR | 9.65% |
2012 | 1.07 Billion EUR | 11.12% |
2011 | 963.83 Million EUR | 19.33% |
2010 | 807.74 Million EUR | -1.55% |
2009 | 820.42 Million EUR | -5.15% |
2008 | 865 Million EUR | 10.34% |
2007 | 783.93 Million EUR | 107.75% |
2006 | 377.34 Million EUR | 2.97% |
2005 | 366.44 Million EUR | 2.66% |
2004 | 356.95 Million EUR | -2.52% |
2003 | 366.19 Million EUR | -8.02% |
2002 | 398.13 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 9.94 Billion EUR | -6.45% |
2024 Q1 | 10.62 Billion EUR | 8.94% |
2024 Q3 | 9.79 Billion EUR | -1.49% |
2023 FY | 9.75 Billion EUR | 39.81% |
2023 Q4 | 9.75 Billion EUR | -2.06% |
2023 Q3 | 9.96 Billion EUR | 41.43% |
2023 Q2 | 7.04 Billion EUR | 1.12% |
2023 Q1 | 6.96 Billion EUR | -0.19% |
2022 Q3 | 7.09 Billion EUR | 13.5% |
2022 Q4 | 6.97 Billion EUR | -1.6% |
2022 Q1 | 5.93 Billion EUR | 4.09% |
2022 Q2 | 6.24 Billion EUR | 5.34% |
2022 FY | 6.97 Billion EUR | 22.46% |
2021 FY | 5.69 Billion EUR | 21.3% |
2021 Q1 | 5.05 Billion EUR | 7.7% |
2021 Q3 | 5.68 Billion EUR | 9.06% |
2021 Q2 | 5.21 Billion EUR | 3.05% |
2021 Q4 | 5.69 Billion EUR | 0.21% |
2020 Q4 | 4.69 Billion EUR | 13.1% |
2020 Q1 | 2.93 Billion EUR | 3.35% |
2020 FY | 4.69 Billion EUR | 65.15% |
2020 Q2 | 3.85 Billion EUR | 30.98% |
2020 Q3 | 4.15 Billion EUR | 7.87% |
2019 Q2 | 2.71 Billion EUR | 2.16% |
2019 FY | 2.84 Billion EUR | 12.56% |
2019 Q4 | 2.84 Billion EUR | 0.65% |
2019 Q3 | 2.82 Billion EUR | 4.02% |
2019 Q1 | 2.65 Billion EUR | 5.23% |
2018 Q3 | 2.51 Billion EUR | 3.99% |
2018 Q2 | 2.41 Billion EUR | 2.74% |
2018 FY | 2.52 Billion EUR | 9.97% |
2018 Q1 | 2.35 Billion EUR | 2.45% |
2018 Q4 | 2.52 Billion EUR | 0.47% |
2017 Q3 | 2.3 Billion EUR | 0.63% |
2017 Q2 | 2.29 Billion EUR | 0.53% |
2017 Q1 | 2.27 Billion EUR | 30.04% |
2017 Q4 | 2.29 Billion EUR | -0.36% |
2017 FY | 2.29 Billion EUR | 31.07% |
2016 Q1 | 1.49 Billion EUR | 3.73% |
2016 Q2 | 1.67 Billion EUR | 12.27% |
2016 FY | 1.75 Billion EUR | 21.97% |
2016 Q3 | 1.73 Billion EUR | 3.69% |
2016 Q4 | 1.75 Billion EUR | 1.0% |
2015 Q4 | 1.43 Billion EUR | 3.2% |
2015 Q2 | 1.33 Billion EUR | 1.91% |
2015 Q1 | 1.3 Billion EUR | 2.9% |
2015 FY | 1.43 Billion EUR | 12.95% |
2015 Q3 | 1.39 Billion EUR | 4.37% |
2014 Q2 | 1.2 Billion EUR | 2.71% |
2014 Q3 | 1.24 Billion EUR | 2.77% |
2014 Q4 | 1.27 Billion EUR | 2.54% |
2014 FY | 1.27 Billion EUR | 8.35% |
2014 Q1 | 1.17 Billion EUR | 0.1% |
2013 Q2 | 1.09 Billion EUR | 0.2% |
2013 Q4 | 1.17 Billion EUR | 6.11% |
2013 Q3 | 1.1 Billion EUR | 0.92% |
2013 Q1 | 1.09 Billion EUR | 2.19% |
2013 FY | 1.17 Billion EUR | 9.65% |
2012 FY | 1.07 Billion EUR | 11.12% |
2012 Q4 | 1.07 Billion EUR | 4.48% |
2012 Q3 | 1.02 Billion EUR | 0.55% |
2012 Q2 | 1.01 Billion EUR | 0.68% |
2012 Q1 | 1.01 Billion EUR | 5.06% |
2011 Q3 | 861.3 Million EUR | 2.65% |
2011 Q2 | 839.1 Million EUR | 2.3% |
2011 FY | 963.83 Million EUR | 19.33% |
2011 Q4 | 963.83 Million EUR | 11.91% |
2011 Q1 | 820.2 Million EUR | 1.54% |
2010 FY | 807.74 Million EUR | -1.55% |
2010 Q4 | 807.74 Million EUR | 0.13% |
2010 Q3 | 806.7 Million EUR | -1.27% |
2010 Q2 | 817.1 Million EUR | -2.49% |
2010 Q1 | 838 Million EUR | 2.14% |
2009 FY | 820.42 Million EUR | -5.15% |
2009 Q4 | 820.42 Million EUR | 0.0% |
2008 FY | 865 Million EUR | 10.34% |
2007 FY | 783.93 Million EUR | 107.75% |
2006 FY | 377.34 Million EUR | 2.97% |
2005 FY | 366.44 Million EUR | 2.66% |
2004 FY | 356.95 Million EUR | -2.52% |
2003 FY | 366.19 Million EUR | -8.02% |
2002 FY | 398.13 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 1.23 Billion EUR | -691.937% |
Carl Zeiss Meditec AG | 3.03 Billion EUR | -221.647% |
Fielmann Aktiengesellschaft | 2.13 Billion EUR | -356.764% |
Gerresheimer AG | 3.42 Billion EUR | -184.482% |
Sartorius Aktiengesellschaft | 9.75 Billion EUR | 0.0% |